Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.60K | 174.50K | 130.30K | -5.53M | 3.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.60K | 174.50K | 130.30K | -5.53M | 3.84M |
| Cost of Revenue | 97.60K | 192.10K | 163.70K | -1.44M | 705.00K |
| Gross Profit | -36.00K | -17.60K | -33.40K | -4.09M | 3.14M |
| SG&A Expenses | 249.10K | 417.50K | 253.90K | -5.10M | 3.84M |
| Depreciation & Amortization | 6.20K | 22.40K | 26.80K | -524.10K | 233.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 352.80K | 632.00K | 444.40K | -7.07M | 4.78M |
| Operating Income | -291.20K | -457.60K | -314.00K | 1.54M | -931.00K |
| Income Before Tax | -290.40K | -1.62M | -325.30K | 2.67M | -1.32M |
| Income Tax Expenses | -- | -- | -- | -65.30K | -- |
| Earnings from Continuing Operations | -290.40K | -1.62M | -325.30K | 2.73M | -1.32M |
| Earnings from Discontinued Operations | -- | -- | -395.80K | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -290.40K | -1.22M | -721.10K | 9.77M | -1.32M |
| EBIT | -291.20K | -457.60K | -314.00K | 1.54M | -931.00K |
| EBITDA | -283.10K | -445.60K | -297.30K | 1.59M | -748.70K |
| EPS Basic | 0.00 | -0.01 | -0.01 | 0.11 | -0.02 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.02 | -0.01 |
| EPS Diluted | 0.00 | -0.02 | -0.01 | 0.11 | -0.02 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.02 | -0.01 |
| Average Basic Shares Outstanding | 87.10M | 87.10M | 87.10M | 87.10M | 87.10M |
| Average Diluted Shares Outstanding | 96.10M | 87.10M | 87.10M | 87.43M | 96.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |